| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-DHRS4 (1-278) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:1000-1:2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
DHRS4 |
| Gene ID: |
10901 |
| Uniprot ID: |
DHRS4_HUMAN |
| Immunogen Region: |
1-278 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-278 of human DHRS4 (NP_066284.2). |
| Immunogen Sequence: |
MHKAGLLGLCARAWNSVRMA SSGMTRRDPLANKVALVTAS TDGIGFAIARRLAQDGAHVV VSSRKQQNVDQAVATLQGEG LSVTGTVCHVGKAEDRERLV ATAVKLHGGIDILVSNAAVN PFFGSIMDVTEEVWDKTLDI NVKAPALMTKAVVPEMEKRG GGSVVIVSSIAAFSPSPGFS PYNVSKTALLGLTKTLAIEL APRNIRVNCLAPGLIKTSFS RMLWMDKEKEESMKETLRI |
| Tissue Specificity | Isoform 1: Predominantly expressed in normal cervix (at protein level). Isoform 4: Expressed in some neoplastic cervical tissues, but not in normal cervix (at protein level). Isoform 5: Expressed in a few neoplastic cervical tissues. Isoform 6: Expressed in a few neoplastic cervical tissues. Isoform 8: High expression in liver. |
| Function | NADPH-dependent oxidoreductase which catalyzes the reduction of a variety of compounds bearing carbonyl groups including ketosteroids, alpha-dicarbonyl compounds, aldehydes, aromatic ketones and quinones. Reduces 3-ketosteroids and benzil into 3beta-hydroxysteroids and R-benzoin, respectively, in contrast to the stereoselectivity of non-primate DHRS4s which produce 3alpha-hydroxysteroids and S-benzoin. Diplays low activity toward all-trans-retinal and no activity toward 9-cis-retinal as compared to non-primate mammals. In the reverse reaction, catalyze the NAD-dependent oxidation of 3beta-hydroxysteroids and alcohol, but with much lower efficiency. Involved in the metabolism of 3beta-hydroxysteroids, isatin and xenobiotic carbonyl compounds. Isoform 7: No detected catalytic activity in vitro, possibly due to the lack of catalytic site. Isoform 8: NADPH-dependent oxidoreductase which catalyzes the reduction of a variety of compounds bearing carbonyl groups including ketosteroids, alpha-dicarbonyl compounds, aldehydes, aromatic ketones and quinones. Involved in the metabolism of 3beta-hydroxysteroids, isatin and xenobiotic carbonyl compounds. Has a higher catalytic activity for xenobiotic alpha-dicarbonyl compounds, sucha as benzil, than isoform 1 and is involved in benzil detoxification. |
| Protein Name | Dehydrogenase/Reductase Sdr Family Member 4Nadph-Dependent Carbonyl ReductaseCrNadph-Dependent Retinol Dehydrogenase/ReductaseNrdrHumnrdrPeroxisomal Short-Chain Alcohol DehydrogenasePscdScad-SrlShort Chain Dehydrogenase/Reductase Family 25c Member 2Protein Sdr25c2Short-Chain Dehydrogenase/Reductase Family Member 4 |
| Database Links | Reactome: R-HSA-5365859Reactome: R-HSA-9033241 |
| Cellular Localisation | Isoform 1: PeroxisomeIsoform 4 Is Not PeroxisomalIsoform 7: Nucleus |
| Alternative Antibody Names | Anti-Dehydrogenase/Reductase Sdr Family Member 4 antibodyAnti-Nadph-Dependent Carbonyl Reductase antibodyAnti-Cr antibodyAnti-Nadph-Dependent Retinol Dehydrogenase/Reductase antibodyAnti-Nrdr antibodyAnti-Humnrdr antibodyAnti-Peroxisomal Short-Chain Alcohol Dehydrogenase antibodyAnti-Pscd antibodyAnti-Scad-Srl antibodyAnti-Short Chain Dehydrogenase/Reductase Family 25c Member 2 antibodyAnti-Protein Sdr25c2 antibodyAnti-Short-Chain Dehydrogenase/Reductase Family Member 4 antibodyAnti-DHRS4 antibodyAnti-SDR25C2 antibodyAnti-UNQ851 antibodyAnti-PRO1800 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
